Bionano Genomics, Inc. (BNGO)
1.20
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Bionano Genomics Profit Margin (Quarterly) : -90.85% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -90.85% |
| March 31, 2026 | -124.2% |
| December 31, 2025 | -99.77% |
| September 30, 2025 | -115.4% |
| June 30, 2025 | -101.8% |
| March 31, 2025 | -48.04% |
| December 31, 2024 | -246.5% |
| September 30, 2024 | -728.6% |
| June 30, 2024 | -208.8% |
| March 31, 2024 | -358.3% |
| December 31, 2023 | -409.4% |
| September 30, 2023 | -1.21K% |
| June 30, 2023 | -449.2% |
| March 31, 2023 | -500.7% |
| December 31, 2022 | -470.8% |
| September 30, 2022 | -440.5% |
| June 30, 2022 | -482.1% |
| March 31, 2022 | -525.8% |
| December 31, 2021 | -364.2% |
| Date | Value |
|---|---|
| September 30, 2021 | -445.8% |
| June 30, 2021 | -487.2% |
| March 31, 2021 | -314.0% |
| December 31, 2020 | -294.0% |
| September 30, 2020 | -491.4% |
| June 30, 2020 | -683.1% |
| March 31, 2020 | -925.2% |
| December 31, 2019 | -283.3% |
| September 30, 2019 | -193.1% |
| June 30, 2019 | -352.5% |
| March 31, 2019 | -423.8% |
| December 31, 2018 | -159.7% |
| September 30, 2018 | -174.1% |
| June 30, 2018 | -97.68% |
| March 31, 2018 | -217.6% |
| September 30, 2017 | -185.4% |
| June 30, 2017 | -303.9% |
| March 31, 2017 | -330.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 19.28% |
| Bio-Rad Laboratories, Inc. | 57.05% |
| Bruker Corp. | -6.07% |
| Danaher Corp. | 13.89% |
| Harvard Bioscience, Inc. | -12.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.07% |
| Return on Assets | -47.15% |
| Return on Invested Capital | -56.22% |
| Gross Profit Margin (Quarterly) | 52.80% |
| Operating Margin (Quarterly) | -88.34% |
| Return on Net Operating Assets | -86.47% |